SBIR/STTR Research Award
Microfabrication based Biomimetic Approach for In Vitro Red Blood Cell Maturation
Award amount
$225,000Program and phase
STTR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Simpore Inc.
- Proposal award date
- 2017-07-20
- Contract end date
- 2019-07-19
- UEI
- NYNDZ3F46K36
- Solicitation number
- HL15-004
- Topic code
- NHLBI
Research abstract
Abstract
The overall goal of this proposal is to develop systems for efficient ex vivo maturation of functional
human red blood cells RBCs which holds tremendous potential for addressing supply bottlenecks for
delivering new therapeutic options to chronically transfused patients with severe alloimmunization and for
novel strategies for delivering therapeutics via engineered RBCs No approaches developed so far have
shown the ability to produce both enucleated and mature RBCs that have reliable shelf life in storage or
viability upon transfusion Our hypothesis is that in existing culture systems late stage erythroblasts early
reticulocytes lose too much surface area during enucleation and membrane remodeling leading to more
spherical cells that are susceptible to hemolysis We propose a biomimetic approach wherein cells are
passed through microslit filters to recapitulate in vivo mechanical deformations that appropriately
constrain cell area volume promote proper biconcave disc morphology and limit potentially harmful
extensional stretching
This proposal brings together expertise in microfabrication at SiMPore Inc with RBC biology and
rheology at the University of Rochester SiMPore will optimize micro slit manufacturing methods and
integrate microslit filter membranes into fluidic systems for RBC maturation testing at Rochester Aim
Similar efforts will be carried out to test the capability of microslit filters to separate and concentrate
mature enucleated RBCs from nucleated precursors Aim Relevant experts will guide developing
regulatory and commercialization plans so that the team is positioned to carry out clinical studies during
Phase II The developed RBC maturation tools can be married with existing large volume bioreactors for
RBC precursor expansion so that final maturation using this approach can be scaled for practical
volumes Narrative
A limitation on the blood supply is the inability to grow mature red blood cells RBCs using
current culturing methods In this project novel filtration technology will be developed for
completing the maturation of cultured RBCs into functionally mature forms and for isolating and
concentrating these forms for potential use as a transfusion product
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Commercializing the μSIM: A Modular Platform for the Development and Analysis of Barrier Tissue Models
- Commercialization of Novel Silicon Microslit Filters for Microplastic Contamination Testing
- Commercializing the µSIM:A Modular Platform for the Development and Analysis of Barrier Tissue Models
- SEA-PUR: A New Platform for Improved Microplastic Contamination Surveillance
- Isoporous Silicon Nanomembranes for Purification of Therapeutic Viruses
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications